Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
Providing bespoke advice on all aspects of traditional IPOs, major SPAC transactions, and complex direct listings, Fenwick & West LLP deploys lawyers with genuine expertise in the tech and life science fields. Balancing its offering between issuers and managers, the practice has experience in representing investor-backed startups and high-growth companies, with Santa Monica-based co-head Ran Ben-Tzur being an expert in equity and debt offerings, alongside SEC compliance measures. The other lead Amanda Rose is a corporate finance specialist, while Robert Freedman joins her in Seattle, concentrating on de-SPACs and direct listings. From Silicon Valley, Gordon Davidson mainly assists clean tech and pharma companies, and David Michaels is knowledgeable in financing transactions. In New York, Per Chilstrom is also a key name.
L’éditorial du Legal 500
Clients clés
- Achieve Life Sciences
- Alpine Immune Sciences, Inc.
Points forts
- Represented Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a biotechnology company dedicated to discovering and developing innovative, protein-based immunotherapies, in its acquisition by Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX).
- Represented BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, in its upsized initial public offering of 12,650,000 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase 1,650,000 additional shares, at a public offering price of $18.00 per share.